ライフサイエンスコーパス: sham

1 interventions were at least as acceptable as sham.

2 and deep rTMS) were not more effective than sham.

3 and early reperfusion with RIPC and/or with sham.

4 50% of patients with active DBS compared to sham.

5 Five DC intensities (sham, 0.5, 1.0, 1.5 and 2.0 mA) were investigated in sep

6 al and Spatial WM training paired with tDCS (sham, 1, 1.5, 2 mA).

7 The control conditions were as follows: (1) sham, (2) transcranial random noise stimulation (tRNS) i

8 to 12 (3.6-22.5) at follow-up, compared with sham: 22.8 (8.4-38.2) at baseline to 16.8 (4.8-33.6) at

9 ment (PENFS: median score 5.0 [IQR 4.0-7.0]; sham: 7.0 [5.0-9.0]; least square means estimate of chan

10 aseline to 6.0 (5.0-8.0) at follow-up versus sham: 7.5 (6.0-9.0) at baseline to 7.0 (5.0-8.0) at foll

11 leg area following distal, but not local or sham, acupuncture.

12 alesional hand area following verum, but not sham, acupuncture; (ii) ipsilesional hand area following

13 hand area following local, but not distal or sham, acupuncture; and (iii) ipsilesional leg area follo

14 free T4 level (depending on the trial), with sham adjustments for placebo.

15 reater reduction in worst pain compared with sham after 3 weeks of treatment (PENFS: median score 5.0

16 apamin enhanced the input-output function in sham, although not in HF rats.

17 as decreased only in MI-CHF rats compared to Sham and AV-CHF rats.

18 The HDC/HA/HR axis was ablated in sham and BDL Kit(W-sh) mice.

19 Treatment of sham and BDL rats with recombinant galanin increased cho

20 Male Wistar rats were divided into Sham and BOO groups.

21 easured at rest and during CBC activation in sham and CHF rabbits.

22 airwise comparisons (ranibizumab, 0.5 mg, vs sham and laser; ranibizumab, 0.3 mg, vs sham) were perfo

23 unction, and blood pressure were examined in sham and mineralocorticoid excess-treated mice with a co

24 Nontreated, sham and naive rats were also included.

25 Rs evoked similar inward currents in MNCs of sham and renovascular hypertensive (RVH) rats.

26 ectrophysiology and real-time PCR in MNCs in sham and renovascular hypertensive (RVH) rats.

27 A (PCoA) in isolated heart mitochondria from Sham and streptozotocin (STZ)-induced type 1 diabetic (T

28 H2O2 emission flux, increasing thereafter in Sham and T1DM GPs under both states 4 and 3 respiration

29 cium dynamics in myocytes from control rats (SHAM) and aortic-banded rats exhibiting diastolic dysfun

30 oing coronary occlusion/reperfusion without (sham) and with RIPC.

31 level data from 6 randomized, double-masked, sham- and laser-controlled clinical trials.

32 Next, we studied sham- and LHb-lesioned rats in our operant CTA paradigm

33 obstructed kidney, the ipsilateral kidney of sham animals, and other tissues.

34 ial duration (APD) in TAC and leptin-treated sham animals, whereas, following TAC, leptin reduced the

35 h-threshold CSNs from CCI mice compared with sham animals, with no differences in cold-induced TRPM8-

36 rned to levels approaching those observed in sham animals.

37 (TB: 0.56 +/- 0.32, P = .003) and extranasal sham application (IB: 0.37 +/- 0.29, P = .001) (TB: 0.39

38 hich brain responses to light touch (but not sham) are attenuated at the time of discharge from the h

39 l, and Young's modulus was 2-fold greater in shams at 1 week post ligation, and 3-fold greater 2 week

40 lied NMDA inhibited IA in MNCs obtained from sham, but not in MNCs from renovascular hypertensive (RV

41 coplasmic reticulum Ca content compared with sham cardiomyocytes.

42 Compared to sham, CHF rats exhibit a reduced increase in the slope o

43 re compared to an identical protocol, with a sham condition during polysomnogram.

44 found for anodal tDCS over the right SMG or sham condition.

45 omly assigned to renal denervation (n=38) or sham control (n=42) and followed up for 3 months.

46 in a greater reduction in PCWP compared with sham control (P=0.028 accounting for all stages of exerc

47 ariates, with the primary comparison between sham control and 0.2 mug/day FAc.

48 eatment group underwent standard CXL and the sham control group received riboflavin alone without rem

49 atment group underwent standard CXL, and the sham control group received riboflavin alone without rem

50 required for NADPH oxidase activation, than sham control kidneys, and genetic deletion of Rac1 in SM

51 but exhibited no mortality when undergoing a sham control operation.

52 th diabetic macular edema (DME) who received sham control or FAc 0.2 or 0.5 mug/day.

53 the integrated FAME data set, compared with sham control-treated subjects, time to first PDR event w

54 anged during TTX had returned to that of the sham control.

55 TTX to a reduction of only 24% compared with sham control.

56 s statistically significantly different from sham control.

57 re randomly assigned to renal denervation or sham control.

58 ignificantly different AK clearance from the sham control.

59 This was a double-blind randomized sham controlled pilot study of transcranial direct curre

60 tACS was applied using a sham-controlled crossover design at individualized inten

61 ference in response during the double-blind, sham-controlled phase (12 [20%] patients in the stimulat

62 This single-center, masked, sham-controlled randomized clinical trial was performed

63 0 mA) for both anodal and cathodal tDCS in a sham-controlled repeated measures design, monitoring cha

64 e = 67.1 years) in a double-blind cross-over sham-controlled study.

65 We conducted the first randomized sham-controlled trial to evaluate the IASD in HF with EF

66 stant depression, a prospective, randomised, sham-controlled trial was conducted.

67 In this randomised, sham-controlled trial, we enrolled adolescents (aged 11-

68 fts as part of an NIH-sponsored double-blind sham-controlled trial.

69 pressant efficacy in a 6-month double-blind, sham-controlled trial.

70 METHODS AND In the current, double-blind, sham-controlled, all-comer trial, patients undergoing di

71 We conducted a randomized, double-blind, sham-controlled, phase 3 efficacy and safety trial of nu

72 re, international, single-blind, randomised, sham-controlled, proof-of-concept trial.

73 shortening %, 27.53 +/- 0.50) compared with sham controls (ejection fraction %, 73.57 +/- 0.20; frac

74 thresholds of SNL rats, but had no effect in sham controls.

75 ficantly lower in the real RDN group than in sham controls; damaged nerves were found only in the rea

76 Ten animals were used as sham-controls.

77 severity compared with subjects who received sham; conversely, fewer subjects treated with FAc experi

78 tter and randomised to 6 months of active or sham DBS, followed by 6 months of open-label subcallosal

79 events during DDD-CLS and 21 (45.7%) during sham DDI (hazard ratio: 6.7; 95% CI: 2.3 to 19.8).

80 at 30 pulses/min for 12 months (group A), or sham DDI mode for 12 months followed by DDD-CLS pacing f

81 her DDD-CLS pacing for 12 months followed by sham DDI mode pacing at 30 pulses/min for 12 months (gro

82 mised double-blind trial comparing active to sham deep brain stimulation (DBS) in the anterior limb o

83 of the non-covalent interactions using Kohn-Sham density functional calculations.

84 nvestigated within the framework of the Kohn-Sham density functional theory (DFT) at the B3LYP/6-31G(

85 ds is presented within the framework of Kohn-Sham density functional theory based on spin projection

86 ve mandibular advancement device (n = 75) or sham device (n = 75).

87 ent device versus 5.6 (2.3) h/night with the sham device (P = 0.006).

88 effective mandibular advancement device or a sham device.

89 nt of endothelial function compared with the sham device.

90 on the low FODMAP diet (173 +/- 95) than the sham diet (224 +/- 89) (P = .001), but not different bet

91 diet (8.8 rRNA genes/g) than patients on the sham diet (9.2 rRNA genes/g) (P = .008), but higher in p

92 ad adequate symptom relief (57%) than in the sham diet group (38%), although the difference was not s

93 ad adequate symptom relief (61%) than in the sham diet group (39%) (P = .042).

94 ded) to groups given counselling to follow a sham diet or diet low in FODMAPs for 4 weeks, along with

95 The sham diet restricted a similar number of staple and non-

96 ulation, resulting in 4 groups (27 receiving sham diet/placebo, 26 receiving sham diet/probiotic, 24

97 27 receiving sham diet/placebo, 26 receiving sham diet/probiotic, 24 receiving low FODMAP diet /place

98 l to the more affected hand; and (iii) local sham electro-acupuncture using non-penetrating placebo n

99 e BE segment ablated circumferentially) or a sham endoscopic procedure; patients in the sham group we

100 zation in UNx EPI cardiomyocytes compared to sham EPI cardiomyocytes.

101 amples, bypassing the need to solve the Kohn-Sham equations.

102 onal that avoids direct solution of the Kohn-Sham equations.

103 le in psoriasiform dermatitis is explored by Shams et al.

104 2 separate randomized-masked ITN treatments (sham extranasal or intranasal).

105 hort (Michigan, n = 16) underwent 4 weeks of sham followed by open-label rTMS for nonresponders (n =

106 S, patients were randomized to active DBS or sham for 3 months, followed by crossover for another 3-m

107 16.8-33.3] to 8.4 [3.2-16.2]) compared with sham (from 22.8 [IQR 8.4-38.2] to 15.2 [4.4-36.8]) with

108 turbance score improved by 3.2 vs 0.1 in the sham group (difference, -3.0; 95% CI, -4.3 to -1.7; P <

109 n the YAG laser group and by -0.6 letters in sham group (difference, 0.4; 95% CI, -6.5 to 5.3; P = .9

110 ly improved symptoms vs 0 individuals in the sham group (difference, 53%; 95% CI, 36%-69%, P < .001).

111 The sham group was offered open-label treatment after unblin

112 ts in the PENFS group and 47 patients in the sham group were included in the primary analysis.

113 a sham endoscopic procedure; patients in the sham group were offered RFA treatment 1 year later, and

114 reatment (n=1 in the PENFS group; n=7 in the sham group) and those who were excluded after randomisat

115 disease (n=2 in the PENFS group; n=1 in the sham group), 57 patients in the PENFS group and 47 patie

116 (n=6; three in the PENFS group, three in the sham group), adhesive allergy (n=3; one in the PENFS gro

117 rgy (n=3; one in the PENFS group, two in the sham group), and syncope due to needle phobia (n=1; in t

118 ix animals in each group) into sham surgery (sham group), left anterior descending (LAD) ligation of

119 nd syncope due to needle phobia (n=1; in the sham group).

120 YAG laser group and 61.1 [6.6] years for the sham group).

121 In the anodal tDCS group, compared with the sham group, VAS ratings for hunger and the urge to eat d

122 ivity in both motor cortices relative to the sham group.

123 ectrocardiographic QTc interval than did the sham group.

124 of Adelta-fibers compared with those of the Sham group.

125 perforation technique, whereas the control (sham) group was subjected to abdominal surgery without c

126 The 'real' and 'sham' groups did not differ in online working memory tas

127 diac MSCs and subcutaneous MSCs from LVD and sham hearts did not improve LV remodeling and function,

128 d-type) and TSLP receptor-knockout mice with sham HeLa cell lysate or RV.

129 s forms of aura symptoms induced by hypoxia, sham hypoxia, or physical exercise with concurrent photo

130 test this, young female SD rats were either sham implanted or implanted s.c. with slow-release E2 pe

131 in combination with ranibizumab 0.5 mg, and sham in combination with ranibizumab 0.5 mg (anti-VEGF m

132 ion at early reperfusion with RIPC than with sham in patients.

133 ocal and distal) acupuncture was superior to sham in producing improvements in neurophysiological out

134 group A: polymicrobial-infected and group B: sham-infected).

135 roup and two rats with three implants in the sham-infection group were analyzed.

136 The control group received a sham infiltration of paravertebral musculature with the

137 d accumulation of bisretinoids compared with sham-injected STGD1 control mice.

138 mg) every 8 weeks after 5 monthly doses with sham injections on nontreatment visits starting at week

139 Sham interventions (n = 8) served as controls.

140 The population doubling times (DT) of sham-irradiated cells varied from 18.9 to 28.7 hours for

141 recovered and grew with the same rate as the sham-irradiated cells.

142 ion in the irradiated samples to that of the sham-irradiated ones varied from 0.6 to 0.8 after 0.2 Gy

143 THODS AND Ten pigs were randomized to either sham irradiation or irradiation of the atrioventricular

144 d structure of the exact multiplicative Kohn-Sham (KS) potential substantially underestimates the fun

145 ard expression for the work function in Kohn-Sham (KS) theory is shown to be valid in generalized KS

146 h ranibizumab, 0.3 mg; and 581 patients with sham/laser.

147 weeks transverse aortic constriction versus sham, linked to enhanced insulin signaling in liver and

148 to-noise ratio (CNR) was found compared with sham (mean CNR, 1.81 [95% confidence interval {CI}: 1.53

149 n increased CNR was also found compared with sham mice (mean CNR, 1.33 [95% CI: 1.27, 1.40] vs 0.98 [

150 e convulsant pentylenetetrazol compared with sham mice, associated with abnormal hippocampal mossy fi

151 ns was similar between bleomycin-treated and sham mice.

152 among neurons from CCI animals compared with sham mice.

153 reased by 23%, respectively, relative to the SHAM model.

154 ) surgery and compared among 4 study groups: SHAM (n = 10), TAC (n = 12), MET (metoprolol, positive d

155 nd after 20 min of 1.5 mA anodal (n = 18) or sham (n = 14) tDCS applied to the right posterolateral c

156 ere 8-10 weeks old underwent TAR (n = 55) or sham (n = 26) surgery.

157 Sprague-Dawley rats underwent UNx (n = 6) or sham (n = 6) operations.

158 ants were randomised to active (n=12) versus sham (n=13) DBS for 16 weeks.

159 s were randomly assigned to active (n=60) or sham (n=30) stimulation between April 10, 2008, and Nov

160 either PENFS (n=60) with an active device or sham (n=55).

161 Compared with sham, NEI VFQ-25 revealed improved general vision (diffe

162 randomisation scheme to active treatment or sham (no electrical charge) for 4 weeks.

163 nd calcium dynamics in myocytes from control sham operated rats and aortic-banded rats exhibiting dia

164 rats had increased TNF and NFkB compared to sham operated rats, and their reduction by IFX was assoc

165 (P-V) loop analysis in approximately 12-week sham-operated and myocardial infarcted (MI) rats.

166 Sham-operated animals served as controls.

167 In cells from sham-operated animals, focal application of acetylcholin

168 to 7 days atrial tachypacing, as well as in sham-operated control pigs.

169 Comparison was made against sham-operated controls and naive animals.

170 When subjected to LPS or CLP, compared with sham-operated controls, CKD mice exhibited exacerbation

171 responses to CSAR in CHF animals compared to sham-operated controls.

172 d to the epicardial surface of infarcted and sham-operated hearts in which a suture was placed around

173 Swiss male mice were randomly assigned to Sham-operated mice (n = 10), MCAO mice receiving the veh

174 Myocardial biopsies from HF, but not sham-operated mice, demonstrated high molecular weight C

175 When compared with sham-operated mice, mice with HF (8 weeks after ligation

176 A group of untreated sham-operated rats was also studied.

177 rats with a range of infarct sizes, plus 14 sham-operated rats, were examined by cine and phase-cont

178 ts with ipsilateral POR plus PER lesions and sham-operated rats.

179 implants in the surgical legs compared with sham-operated surgical legs without implant placement an

180 yperammonemic portacaval anastomosis rat and sham-operated, pair-fed Sprague-Dawley rats treated with

181 Rats (naive, sham-operated, TBI) underwent a moderate controlled cort

182 ilateral common carotid artery stenosis or a sham operation and fed normal or cilostazol diet for thr

183 sed in WT mice compared to mice undergoing a sham operation, however leukocyte attachment was reduced

184 Compared with sham operation, nephrectomy resulted in significant incr

185 hours after 30 minutes of renal ischemia or sham operation.

186 arotid artery of male FVB mice and performed sham operations for 2 weeks.

187 n ambulatory settings with SMT compared with sham or alternative treatments, and that measured pain o

188 als that compared any rTMS intervention with sham or another rTMS intervention.

189 pe (WT) and Kit(W-sh) mice were subjected to sham or BDL for up to 7 days and Kit(W-sh) mice were inj

190 ep) mice (8 weeks of age) were randomized to sham or burn injury consisting of a dorsal scald burn in

191 mbrane-bound ovalbumin transgenic mice after sham or IRI procedures.

192 Two weeks later, a sham or real RDN treatment was performed bilaterally usi

193 rague-Dawley rats (n = 32) were subjected to sham or volume overload to induce HFpEF.

194 test-induced vasovagal syncope compared with sham pacing.

195 The aim of a sham (placebo) surgery CT is to carry out a surgical CT

196 etic training compared to those who received sham (placebo) tRNS.

197 s were randomized (1:1) to the IASD versus a sham procedure (femoral venous access with intracardiac

198 ubjects randomized to medical therapy with a sham procedure (right heart catheterization) versus medi

199 ere randomized (2:1) to FUS thalamotomy or a sham procedure at 2 centers from October18, 2012, to Jan

200 er transient myocardial ischemia (45 min) or sham procedure.

201 columbar spine at 24 hours compared with the sham procedure.

202 ized to unilateral FUS thalamotomy, and 7 to sham procedure.

203 s was performed in mice after hepatic RFA or sham procedure; mice were sacrificed 24 hours to 7 days

204 - 0.7 with RFA alone, and 15 mm +/- 0.7 with sham procedure; P < .001).

205 RDN (control-RDN, n = 8; CKD-RDN, n = 7) or sham procedures (control-intact, n = 6; CKD-intact, n =

206 c short hair cats (n = 20), underwent either sham procedures (n = 8) or aortic constriction (n = 12)

207 baseline of 25 points (IQR, 15.0-33.0) after sham procedures.

208 baseline of 23 points (IQR, 14.0-27.0) after sham procedures; the between-group difference was signif

209 In sham rats, acute CSAR activation by epicardial applicati

210 by exogenously applied NMDA inhibited IA in sham rats, but this effect was largely blunted in RVH ra

211 onged NMDAR-DeltaCa(2+) responses in MNCs of sham rats, but this effect was occluded in RVH rats, thu

212 rats whereas lidocaine had little effect in sham rats, indicating that the CSAR is tonically active

213 m) strengthened the input-output function in sham rats, it failed to have an effect in HF rats.

214 thetic nerve activity in CHF rats but not in sham rats.

215 ction of MNCs was enhanced in HF compared to sham rats.

216 elevated LVEDP, neither of which was seen in sham rats.

217 ession of SK2/SK3 subunits in HF compared to sham rats.

218 load) in CHF rats, which was not observed in sham rats.

219 s in rats with gp120 was higher than that in sham rats.

220 load) in CHF rats, which was not observed in sham rats.

221 he end-diastolic P-V relationship (EDPVR) in sham rats.

222 ctility to a greater extent in CHF rats than sham rats.

223 In behavioral studies, MAM (vs. SHAM) rats displayed abnormal orbitofrontal cortex-media

224 SHAM) rats had lower/higher structural connectivity in a

225 of schizophrenia and saline-treated control (SHAM) rats, in conjunction with immunohistochemistry, my

226 ncrease in the rate of spontaneous VAs after sham RDN (P=0.03).

227 gnificantly above those levels in respective sham-RDN rats, and at the end of the 12-week study, rats

228 ting NP as compared to those associated with sham-RDN.

229 and WKY underwent either bilateral RF-RDN or sham-RDN.

230 Shams received volume-matched saline; PE and SU groups r

231 mean +/- SD; chronic heart failure (CHF) vs. Sham, respectively] a marked increase in the incidence o

232 early reperfusion with RIPC in comparison to sham revealed a relation to mitochondria and cytoskeleto

233 blinded to the laterality of microneedle and sham roller assignments.

234 ment with a microneedle roller (200 um) vs a sham roller.

235 sponse to active (r = -.52, p < .05) but not sham rTMS in our secondary cohort.

236 N3) improved after real-rTMS (and not after sham-rTMS) compared with baseline (p=0.029 and p=0.015,

237 experimental sessions (baseline, real-rTMS, sham-rTMS), all including an N-back task (3 task loads:

238 shortening %, 42.33 +/- 5.70) compared with sham S2814A mice (ejection fraction %, 71.60 +/- 4.02; f

239 least 30,000 scientific papers used the Kohn-Sham scheme of density functional theory to solve electr

240 d (RADPAD), standard treatment (NOPAD), or a sham shield (SHAMPAD).

241 The sham shield allowed testing for shield-induced radiation

242 , average AK clearance was 76% vs 58% on the sham side (P < .01), including 3 patients with complete

243 reated side was 43% compared with 38% on the sham side (P = .66).

244 cantly different between the microneedle and sham sides (0.7 and 0.4; P = .28), respectively.

245 cantly different between the microneedle and sham sides, 4.5 mm and 3.4 mm (P = .21), respectively.

246 Except for theta-burst stimulation vs sham, similar results were obtained for remission.

247 memory was improved by so-tDCS compared with sham stimulation and was associated with stronger synchr

248 S significantly outperformed those receiving sham stimulation on facial emotion, but not identity, pe

249 ificant interactions comparing active versus sham stimulation over time were evident.

250 formance gains relative to unihemispheric or sham stimulation.

251 patients after real-rTMS when compared with sham stimulation.

252 provement (at both 60 and 90 Hz) relative to sham stimulation.

253 to light touch that differentiate them from sham stimuli in full-term infants.

254 We performed bile-duct ligations or sham surgeries on C57BL/6 or toll-like receptor 4 (TLR4)

255 Mice underwent PH or sham surgeries.

256 Renal artery stenosis surgery (n = 10) or sham surgery (n = 5) was performed, and the stenotic and

257 ere grouped (six animals in each group) into sham surgery (sham group), left anterior descending (LAD

258 s then underwent either ovariectomy (OVX) or sham surgery and thereafter either continued to be fed a

259 ice received a controlled cortical impact or sham surgery at postnatal day 21, approximating a toddle

260 ssible roadmap for the ethical assessment of sham surgery clinical trials (CTs), focusing on methodol

261 , moderate, and mild spinal cord injury, and SHAM surgery, respectively.

262 randomized to cecal ligation and puncture or sham surgery.

263 Sham-surgery and SCNX mice were treated with either Meth

264 roup back to baseline expression observed in sham-surgery controls.

265 pical administrations were performed using a sham suspension (without probiotic).

266 ted in three fMRI scans with 20 Hz, 5 Hz, or sham tACS applied separately on each scan.

267 dal tDCS (atDCS), cathodal tDCS (ctDCS), and sham tDCS (stDCS) over the left sensorimotor region.

268 nodal (i.e., enhancing cortical activity) or sham tDCS aimed at the left DLPFC.

269 Active compared to sham tDCS led to increased performance in the orienting

270 patients to receive tDCS plus oral placebo, sham tDCS plus escitalopram, or sham tDCS plus oral plac

271 ral placebo, sham tDCS plus escitalopram, or sham tDCS plus oral placebo.

272 fore and after receiving cathodal, anodal or sham tDCS to the left DLPFC.

273 CS targeted at the left DLPFC (compared with sham tDCS) has an immediate effect on eating behavior du

274 Relative to sham tDCS, anodal tDCS increased activation in right Cru

275 intake or thereby weight change, relative to sham tDCS.

276 myalgia were randomized to receive active or sham tDCS.

277 Anodal or sham transcranial direct current stimulation (tDCS) was

278 tudy participants received 30 min of real or sham transcranial direct current stimulation applied to

279 BSI and preserved neurite length similar to sham treated cells.

280 esistant to, then inoculated antibiotic- and sham-treated birds with MG.

281 0 degrees C) heating of tissue, as well as a sham-treated control group.

282 y (P value range, <.0001 to .04) relative to sham-treated controls.

283 vived in the rtACS-treated group compared to sham-treated controls.

284 in the lungs of bleomycin-treated mice than sham-treated mice, whereas the distribution in other org

285 1) higher in BDL rats (13.6 +/- 3.2) than in sham-treated rats (5.7 +/- 4.2) and in the CCl4-treated

286 Bile duct-ligated (BDL) and sham-treated rats were imaged 19 days after the procedur

287 provements in mean DR severity compared with sham treatment at months 6, 12, and 18.

288 enocarcinoma tumors were allocated to RFA or sham treatment with or without a STAT3 inhibitor (S3I-20

289 xt, animals were allocated to hepatic RFA or sham treatment with or without STAT3 (signal transducer

290 trials of 9 nonpharmacologic options versus sham treatment, wait list, or usual care, or of 1 nonpha

291 and after ONC in animals receiving rtACS or sham treatment.

292 d two-hour controlled-exposure-experiment to sham under placebo, PM2.5 (250 mug/m(3)) under placebo,

293 young versus old serum and 18 snoRNAs in old sham versus old experimental osteoarthritic serum.

294 To evaluate YAG laser vitreolysis vs sham vitreolysis for symptomatic Weiss ring floaters fro

295 ositive airway pressure (CPAP) compared with sham was significantly associated with reduction of AHI

296 rodents (10 cecal ligation and puncture, 10 sham) were killed at 24 hours, and 20 more at 96 hours.

297 , vs sham and laser; ranibizumab, 0.3 mg, vs sham) were performed using Cox proportional hazard regre

298 rved strain and increased work compared with sham, whereas MICHF had reduced longitudinal strain and

299 anibizumab, 0.5 mg and 0.3 mg, compared with sham with and without laser in DME.

300 andomly assigned to YAG laser vitreolysis or sham YAG (control).